Vitamin d dosing trial aims to halt diabetes in its tracks
NCT ID NCT07448974
First seen Mar 05, 2026 · Last updated May 17, 2026 · Updated 10 times
Summary
This study tests whether taking a weekly dose of vitamin D, adjusted to reach a target blood level, can help control blood sugar in 100 adults aged 30-74 with prediabetes. Participants are randomly assigned to receive either vitamin D or a placebo for about 18 months. The main goal is to see if vitamin D increases the time blood sugar stays in a healthy range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.